Author

Thimmaiah Govindaraju

Jawaharlal Nehru Centre for Advanced Scientific ResearchORCID 0000-0002-9423-4275Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

Madhu RameshiD· 3 shared Devanshi Shah· 1 shared James Premdoss ClementiD· 1 shared Kolla RajasekhariD· 1 shared Maneesha S. InamdariD· 1 shared N. Arul MuruganiD· 1 shared Prathamesh DongreiD· 1 shared Shadab Alam· 1 shared

Activity by Year

2021-2025 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Madhu RameshORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NeuroscienceNAR Molecular MedicinePeer-reviewedJun 30, 2025

MiR-7a-Klf4 axis as a regulator and therapeutic target of neuroinflammation and ferroptosis in Alzheimer's disease

Madhu Ramesh, Thimmaiah Govindaraju

The paper identifies miR-7a-Klf4 as a regulator of neuroinflammation and ferroptosis in Alzheimer's disease and shows its therapeutic potential.

14 citationstop 1%

mousebulk RNA-seq

𝕏 PostBluesky

NeuroscienceJournal of NeuroinflammationPeer-reviewedMar 20, 2025

Asrij/OCIAD1 depletion reduces inflammatory microglial activation and ameliorates Aβ pathology in an Alzheimer's disease mouse model

Prathamesh Dongre, Madhu Ramesh, Thimmaiah Govindaraju, Maneesha S. Inamdar

This study shows that reducing Asrij levels in an Alzheimer's disease mouse model decreases microglial inflammation and Aβ pathology, improving cognitive and neuronal outcomes.

10 citationstop 3%

mouseproteomics

𝕏 PostBluesky

NeuroscienceAdvanced TherapeuticsPeer-reviewedJan 28, 2021

Naphthalene monoimide derivative ameliorates amyloid burden and cognitive decline in a transgenic mouse model of Alzheimer's disease

Sourav Samanta, Kolla Rajasekhar, Madhu Ramesh…·Thimmaiah Govindaraju

This study identifies TGR63, a naphthalene monoimide derivative, as a promising therapeutic for Alzheimer's disease by reducing amyloid burden and cognitive decline in a mouse model.

36 citations

mouseexperimental assay

𝕏 PostBluesky